Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Pralle

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
European Journal of Cancer & Clinical Oncology|August 1, 1985
Aclarubicin (aclacinomycin A) in the treatment of relapsing acute leukaemiasP S Mitrou, R Kuse, H Anger, et al.
The European Respiratory Journal|September 1, 1996
Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedemaH Schütte, J Lohmeyer, S Rosseau, et al.
Blood|July 15, 1993
Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study GroupR Hehlmann, H Heimpel, J Hasford, et al.
Blood|March 1, 1990
Clinical implications of increased plasma levels of CD8 in patients with hairy cell leukemiaA D Ho, M Grossman, L Trümper, et al.
Onkologie|February 1, 1988
[Alpha interferon in the therapy of hairy cell leukemia. Results of 3 prospective multicenter studies in West Germany]H Pralle, A Bartel, S Boedewadt-Radzun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Autologous blood stem-cell transplantation in patients with advanced Hodgkin's disease and prior radiation to the pelvic siteM Körbling, R Holle, R Haas, et al.
Blood|December 15, 1994
Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study GroupR Hehlmann, H Heimpel, J Hasford, et al.
Leukemia|April 1, 1987
A prospective multicenter trial with human recombinant alpha 2c-interferon in hairy cell leukemia before and after splenectomyH Pralle, T Zwingers, S Boedewadt, et al.
Onkologie|February 1, 1987
[Prospective controlled study of therapy of chronic myeloid leukemia (CML)]R Hehlmann, H Heimpel, D K Hossfeld, et al.
Onkologie|February 1, 1987
[Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy]H Pralle, T Zwingers, S Boedewadt, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
European Journal of Cancer & Clinical Oncology|August 1, 1985
Aclarubicin (aclacinomycin A) in the treatment of relapsing acute leukaemiasP S Mitrou, R Kuse, H Anger, et al.
The European Respiratory Journal|September 1, 1996
Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedemaH Schütte, J Lohmeyer, S Rosseau, et al.
Blood|July 15, 1993
Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study GroupR Hehlmann, H Heimpel, J Hasford, et al.
Blood|March 1, 1990
Clinical implications of increased plasma levels of CD8 in patients with hairy cell leukemiaA D Ho, M Grossman, L Trümper, et al.
Onkologie|February 1, 1988
[Alpha interferon in the therapy of hairy cell leukemia. Results of 3 prospective multicenter studies in West Germany]H Pralle, A Bartel, S Boedewadt-Radzun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
Autologous blood stem-cell transplantation in patients with advanced Hodgkin's disease and prior radiation to the pelvic siteM Körbling, R Holle, R Haas, et al.
Blood|December 15, 1994
Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study GroupR Hehlmann, H Heimpel, J Hasford, et al.
Leukemia|April 1, 1987
A prospective multicenter trial with human recombinant alpha 2c-interferon in hairy cell leukemia before and after splenectomyH Pralle, T Zwingers, S Boedewadt, et al.
Onkologie|February 1, 1987
[Prospective controlled study of therapy of chronic myeloid leukemia (CML)]R Hehlmann, H Heimpel, D K Hossfeld, et al.
Onkologie|February 1, 1987
[Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy]H Pralle, T Zwingers, S Boedewadt, et al.
Pageof 11